Showing results (61-70 of 164) with videos related to
Sort By:
Pageof 17
European Journal of Nuclear Medicine and Molecular Imaging|October 22, 2008
Combined evaluation of preoperative FDG uptake on PET, ground-glass opacity area on CT, and serum CEA level: identification of both low and high risk of recurrence in patients with resected T1 lung adenocarcinomaKotaro Higashi, Tsutomu Sakuma, Kengo Ito, et al.Vaccines|December 28, 2021
Attenuation of Antibody Titers from 3 to 6 Months after the Second Dose of the BNT162b2 Vaccine Depends on Sex, with Age and Smoking Risk Factors for Lower Antibody Titers at 6 MonthsYushi Nomura, Michiru Sawahata, Yosikazu Nakamura, et al.Respiratory Medicine Case Reports|November 6, 2024
A case of pulmonary mucosa-associated lymphoid tissue lymphoma diagnosed by detecting t(11;18)(q21;q21) in bronchial lavage fluidYusuke Nakamura, Akihiro Takemasa, Yuki Ohoka, et al.Respiratory Medicine Case Reports|November 11, 2024
A case of acute eosinophilic pneumonia induced by the inhalation of acetyleneNobuhiko Tsukada, Yusuke Nakamura, Shohei Hara, et al.Cancer|August 28, 2003
Weekly chemotherapy with cisplatin, vincristine, doxorubicin, and etoposide is an effective treatment for advanced thymic carcinomaKiyotaka Yoh, Koichi Goto, Gen-ichiro Ishii, et al.Lung Cancer (Amsterdam, Netherlands)|January 15, 2010
Re-challenge chemotherapy for relapsed non-small-cell lung cancerTatsuya Nagano, Young Hak Kim, Koichi Goto, et al.Japanese Journal of Clinical Oncology|January 30, 2014
A Phase III trial comparing irinotecan and cisplatin with etoposide and cisplatin in adjuvant chemotherapy for completely resected pulmonary high-grade neuroendocrine carcinoma (JCOG1205/1206)Junko Eba, Hirotsugu Kenmotsu, Masahiro Tsuboi, et al.Respirology Case Reports|May 7, 2026
A Case of Anti-AMY1-Positive Lung Squamous Cell Carcinoma With Severe Hyperamylasemia Linked to Disease ProgressionYusuke Nakamura, Shohei Hara, Noriaki Nishimura, et al.Pathology International|March 8, 2013
Clinicopathological characteristics of EGFR mutated adenosquamous carcinoma of the lungToshihiro Shiozawa, Genichiro Ishii, Koichi Goto, et al.Lung Cancer (Amsterdam, Netherlands)|September 2, 2015
Impact of single nucleotide polymorphisms on severe hepatotoxicity induced by EGFR tyrosine kinase inhibitors in patients with non-small cell lung cancer harboring EGFR mutationsEri Sugiyama, Shigeki Umemura, Shogo Nomura, et al.Pageof 17